COMBIOM
STRENGTHENING COOPERATION IN MOLECULAR BIOMEDICINE BETWEEN EU AND UKRAINE
| Coordinatore | INSTYTUT MOLEKULYARNOI BIOLOGII I GENETYKY NAN UKRAINY
Organization address
address: ZABOLOTNOGO STREET 150 contact info |
| Nazionalità Coordinatore | Ukraine [UA] |
| Totale costo | 510˙840 € |
| EC contributo | 455˙499 € |
| Programma | FP7-INCO
Specific Programme "Capacities": International co-operation |
| Code Call | FP7-INCO-2011-6 |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-12-01 - 2015-05-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
INSTYTUT MOLEKULYARNOI BIOLOGII I GENETYKY NAN UKRAINY
Organization address
address: ZABOLOTNOGO STREET 150 contact info |
UA (KYIV) | coordinator | 320˙465.00 |
| 2 |
INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY
Organization address
address: ks. Trojdena 4 contact info |
PL (Warsaw) | participant | 80˙036.00 |
| 3 |
INSTITUT GUSTAVE ROUSSY
Organization address
address: Rue Camille Desmoulins 39 contact info |
FR (VILLEJUIF) | participant | 54˙998.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'True European leadership at the emerging frontiers of biomedical sciences could be achieved more effectively with participation of the most prominent scientists from the ENP countries. Ukraine is a country of high potential for scientific and technological development. Institute of Molecular Biology and Genetics is one of the leading scientific centres in molecular biomedicine area in Ukraine, which has rather good results in the fundamental research and development of effective diagnostics and therapy of oncological and neurodegenerative diseases. Widening and deepening the existing bilateral collaboration with two EU partners: Gustave Roussy Institute of Oncology, France, and International Institute of Molecular and Cell Biology, Poland, will provide creation of a new research consortium for enhanced involvement of the Ukrainian research center into the ERA (first objective). Supported by the EU partners the building of international cooperation capacities of the Institute for its successful participation in European collaborative research will elucidate its potential for European community and will result in widening the ERA and engagement of new participants in increased number of successful projects (second objective). Development of the Institute’s Research Strategy as a result of SWOT analysis of its research possibilities in molecular biomedicine under supervision of international Advisory Board with participation of the EU partners is our third objective. Having improved opportunities, the Institute will provide broader activities on popularization of science and raising social awareness of the modern biotechnology and biomedicine benefits (fourth objective). We will leverage the activities of the existing informational unit and use the available electronic media to disseminate knowledge. Ultimately, reinforced S&T potential of the Institute will allow it to become more visible and attractive as a collaborating partner in the European Research Area.'